CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)141-144
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Hormonal Antineoplastic Agents
Cytochrome P-450 CYP2D6
Tamoxifen
Genotype
Neoplasms

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

CYP2D6 genotype and tamoxifen : Considerations for proper nonprospective studies. / Goetz, Matthew Philip; Ingle, J. N.

In: Clinical Pharmacology and Therapeutics, Vol. 96, No. 2, 2014, p. 141-144.

Research output: Contribution to journalArticle

@article{e66ed0ffea5c462980bb6a7d5c5fd6bf,
title = "CYP2D6 genotype and tamoxifen: Considerations for proper nonprospective studies",
author = "Goetz, {Matthew Philip} and Ingle, {J. N.}",
year = "2014",
doi = "10.1038/clpt.2014.99",
language = "English (US)",
volume = "96",
pages = "141--144",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - CYP2D6 genotype and tamoxifen

T2 - Considerations for proper nonprospective studies

AU - Goetz, Matthew Philip

AU - Ingle, J. N.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904808627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904808627&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.99

DO - 10.1038/clpt.2014.99

M3 - Article

C2 - 25056392

AN - SCOPUS:84904808627

VL - 96

SP - 141

EP - 144

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -